… buprenorphine/naloxone inductions of four individuals who tested positive for fentanyl. …
OUD individuals onto buprenorphine/naloxone maintenance, 16, 17 and our use of the …

… of care, with buprenorphine/naloxone generally offered for … study were to assess the impact
of fentanyl use on (1) MOUD … initiating methadone or buprenorphine/naloxone as part of a …

… buprenorphine vs sublingual buprenorphine-naloxone, stratified into subgroups, who (1)
exhibited evidence of fentanyl use … results for fentanyl or norfentanyl (ie, fentanyl positive), or (2) …

… This case series aims to describe micro-dosing to initiate buprenorphine/naloxone in a
fentanyl exposed population in an outpatient setting. We describe both patients on OAT, either …

… Although buprenorphine/naloxone (BUP/NX) is an evidence-based, first-line opioid agonist
… pharmacokinetics of illicit fentanyl use, one animal model did show that multiple boluses of …

… Six studies have also demonstrated the use of transdermal fentanyl or buprenorphine
patches as viable bridging treatments to eliminate withdrawal symptoms during the transition to …

… fentanyl-positive UDT. Our findings highlight high rates of ongoing fentanyl use despite the
use … OAT and support the expansion of BUP/NX for the treatment of people who use fentanyl. …

… a relapse to heroin use and was later stabilised on buprenorphine/naloxone at a daily … to
fentanyl use over the last 2 years. At admission, her urine was positive for cocaine and fentanyl, …

… We present a case in which a critically ill and mechanically ventilated patient was
transitioned from a fentanyl infusion to buprenorphine/naloxone using a rapid micro-induction …

… These include a transdermal fentanyl bridge, a micro-induction technique, and a … use
of a transdermal fentanyl patch to transition patients from methadone to buprenorphine/naloxone. …